Background Inflammation biomarkers have been introduced into clinical practice for risk-
rating in treatment of patients with cancer. We aimed to confirm the prognostic role of platelet …

Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-
invasive and Metastatic bladder cancer (BCa) updates its guidelines yearly. This updated …

CONTEXT: New guidelines of the International Consultation on Urological Diseases for the
treatment of muscle-invasive bladder cancer (MIBC) have recently been published …

CONTEXT: New data regarding treatment of muscle-invasive and metastatic bladder cancer
(MiM-BC) has emerged and led to an update of the European Association of Urology (EAU) …

BACKGROUND The authors evaluated sarcopenia as a predictor of cancer‐specific survival
(CSS) and overall survival (OS) among patients with urothelial cancer of the bladder …

CONTEXT: Muscle-invasive bladder cancer (MIBC) is a disease with a pattern of
predominantly distant and early recurrences. Neoadjuvant cisplatin-based combination …

Purpose: Accurate estimates of risk are essential for physicians if they are to recommend a
specific management to patients with prostate cancer. Accurate risk estimates are also …

Background Pretreatment neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic
inflammation that has been associated with adverse survival in a variety of malignancies …